https://old.international-pharma.com/sonotec-launches-new-generation-of-its-high-accuracy-clamp-on-flow-meter-sonoflow-co-55/ 2023-10-19T22:45:28+00:00 https://old.international-pharma.com/wp-content/uploads/2022/05/sonoflow-co.55-v3.0-portfolio-sonotec-2_1240x800_1.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/sonoflow-co.55-v2.0-v3.0-portfolio-sonotec-2_1240x800_2.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/sonoflow-co.55-0375-v3.0-sonotec-3_1240x800_3.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/sonoflow-co.55-0375-v3.0-sonotec-1_1240x800_4.jpg https://old.international-pharma.com/pci-pharma-services-announces-major-manufacturing-expansion-with-100-million-investment-in-new-england-providing-global-capacity-to-clients/ 2023-10-19T22:45:27+00:00 https://old.international-pharma.com/tower-cold-chain-sets-sights-on-doubling-its-global-network-as-l-a-hub-opens/ 2023-10-19T22:45:26+00:00 https://old.international-pharma.com/wp-content/uploads/2022/05/TOWER-COLD-CHAIN-SETS-SIGHTS-ON-DOUBLING-ITS-GLOBAL-NETWORK-2.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/TOWER-COLD-CHAIN-SETS-SIGHTS-ON-DOUBLING-ITS-GLOBAL-NETWORK-1.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/TOWER-COLD-CHAIN-SETS-SIGHTS-ON-DOUBLING-ITS-GLOBAL-NETWORK-3.jpg https://old.international-pharma.com/london-medical-laboratorys-tests-show-80-of-children-may-develop-allergies-if-parents-have-them/ 2023-10-19T22:45:26+00:00 https://old.international-pharma.com/superdrug-launch-comprehensive-perimenopause-screen-service/ 2023-10-19T22:45:25+00:00 https://old.international-pharma.com/positive-results-for-astrazenecas-asthma-therapy/ 2023-10-19T22:45:24+00:00 https://old.international-pharma.com/avantor-and-cytovance-biologics-collaborate-to-accelerate-plasmid-dna-development-for-biopharma-customers/ 2023-10-19T22:45:24+00:00 https://old.international-pharma.com/live-from-cphi-north-america-pharma-companies-with-esg-more-valuable-say-investors/ 2023-10-19T22:45:19+00:00 https://old.international-pharma.com/pharmapack-europe-awards-winners-2022/ 2023-10-19T22:45:19+00:00 https://old.international-pharma.com/fda-places-hold-on-inmune-bios-alzheimers-trial/ 2023-10-19T22:45:18+00:00 https://old.international-pharma.com/pfizer-biontech-vaccine-effective-against-omicron-in-children-five-and-under/ 2023-10-19T22:45:17+00:00 https://old.international-pharma.com/alternative-to-open-heart-surgery-emerges-following-nihr-research/ 2023-10-19T22:45:16+00:00 https://old.international-pharma.com/new-cardiff-business-school-study-helps-build-tomorrows-intelligent-cold-chain-supply-for-tower/ 2023-10-19T22:45:16+00:00 https://old.international-pharma.com/wp-content/uploads/2022/05/Tower_Cardiff-University-Press-Release-1.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/Tower_Cardiff-University-Press-Release-2.jpg https://old.international-pharma.com/wp-content/uploads/2022/05/Kevin-Doran-Global-Head-of-Supply-Chain-Tower-Cold-Chain.jpg https://old.international-pharma.com/sandoz-unveils-global-biosimilar-initiative/ 2023-10-19T22:45:15+00:00 https://old.international-pharma.com/nice-approves-mercks-keytruda-for-adult-patients-with-rare-triple-negative-breast-cancer/ 2023-10-19T22:45:14+00:00 https://old.international-pharma.com/memo-therapeutics-initiates-pioneering-bk-virus-therapy-trial/ 2023-10-19T22:45:14+00:00 https://old.international-pharma.com/thousands-to-potentially-benefit-from-roche-treatment-for-sight-loss/ 2023-10-19T22:45:13+00:00 https://old.international-pharma.com/nrg-receives-2-68m-funding-boost-for-neurodegenerative-disorders/ 2023-10-19T22:45:09+00:00 https://old.international-pharma.com/novartis-confirms-cyberattack-says-no-sensitive-data-stolen/ 2023-10-19T22:45:08+00:00 https://old.international-pharma.com/fda-approves-gsk-measles-vax/ 2023-10-19T22:45:07+00:00 https://old.international-pharma.com/cambridge-pharma-promises-to-boost-drug-development/ 2023-10-19T22:45:06+00:00 https://old.international-pharma.com/daiichi-sankyo-and-astrazenecas-enhertu-delivers-promising-trial-results/ 2023-10-19T22:45:05+00:00 https://old.international-pharma.com/vertex-trial-for-hypoglycaemia-therapy-shows-early-promise/ 2023-10-19T22:45:04+00:00 https://old.international-pharma.com/bachem-and-eli-lilly-link-up-to-advance-oligonucleotide-products/ 2023-10-19T22:45:04+00:00 https://old.international-pharma.com/humanigen-enters-into-agreement-with-pci-pharma-services-as-part-of-preparations-for-commercialization-in-the-united-kingdom/ 2023-10-19T22:45:03+00:00 https://old.international-pharma.com/owen-mumford-appoints-new-director-of-research-and-development/ 2023-10-19T22:45:02+00:00 https://old.international-pharma.com/wp-content/uploads/2022/06/Owen-Mumford_Bal-Johal-scaled.jpg https://old.international-pharma.com/blood-vessel-breakthrough-is-major-step-towards-alzheimers-treatment/ 2023-10-19T22:45:01+00:00 https://old.international-pharma.com/rmis-covid-19-vaccine-partnership-with-acacium-proves-a-success/ 2023-10-19T22:44:57+00:00 https://old.international-pharma.com/university-of-strathclyde-develops-3d-breast-cancer-screening-tool/ 2023-10-19T22:44:56+00:00 https://old.international-pharma.com/astrazenecas-eplontersen-meets-endpoints-in-critical-phase-3-trial/ 2023-10-19T22:44:56+00:00 https://old.international-pharma.com/bbs-automation-strengthens-medtech-life-sciences-capabilities-with-acquisition-of-kahle-automation-s-r-l/ 2023-10-19T22:44:55+00:00 https://old.international-pharma.com/wp-content/uploads/2022/06/kahle-bbs-logo-1.jpg https://old.international-pharma.com/sanofi-and-gsk-report-successful-efficacy-results-against-omicron/ 2023-10-19T22:44:54+00:00 https://old.international-pharma.com/positive-mhra-decision-for-briviact/ 2023-10-19T22:44:54+00:00 https://old.international-pharma.com/abbvies-rinvoq-gains-recommended-approval-by-chmp/ 2023-10-19T22:44:53+00:00 https://old.international-pharma.com/eu-approves-norvatis-cosentyx-for-childhood-arthritis/ 2023-10-19T22:44:53+00:00 https://old.international-pharma.com/novo-nordisk-to-build-on-heritage-in-rare-blood-disorders/ 2023-10-19T22:44:52+00:00 https://old.international-pharma.com/maintaining-integrity-of-the-pharma-cold-chain/ 2023-10-19T22:44:51+00:00 https://old.international-pharma.com/listening-to-healthcare-professionals-and-patients-through-co-creation/ 2023-10-19T22:44:47+00:00 https://old.international-pharma.com/financial-barriers-to-participation-the-missing-piece-of-the-patient-centric-jigsaw/ 2023-10-19T22:44:47+00:00 https://old.international-pharma.com/the-benefits-of-patient-centricity-in-clinical-trials-how-it-can-support-clinical-operations-and-study-adherence/ 2023-10-19T22:44:46+00:00 https://old.international-pharma.com/tackling-pharmas-shadow-market-getting-smarter-in-the-fight-against-fake-pharmaceuticals/ 2023-10-19T22:44:45+00:00 https://old.international-pharma.com/shared-care-strengthening-self-management-support-for-chronic-patients/ 2023-10-19T22:44:45+00:00 https://old.international-pharma.com/making-a-case-for-a-fixed-dose-combination-drug-strategy/ 2023-10-19T22:44:44+00:00 https://old.international-pharma.com/new-manufacturing-technology-platforms-for-biosimilars/ 2023-10-19T22:44:43+00:00 https://old.international-pharma.com/big-strides-in-small-batch-aseptic-processing/ 2023-10-19T22:44:43+00:00 https://old.international-pharma.com/does-remote-pharma-gmp-auditing-have-a-future/ 2023-10-19T22:44:42+00:00 https://old.international-pharma.com/the-importance-of-user-insights-in-digital-product-design/ 2023-10-19T22:44:41+00:00 https://old.international-pharma.com/covid-19-and-sepsis-co-infection-the-impact-of-advanced-detection-and-diagnosis/ 2023-10-19T22:44:37+00:00 https://old.international-pharma.com/transforming-the-status-quo-through-digitalisation-and-ai/ 2023-10-19T22:44:37+00:00 https://old.international-pharma.com/achieving-faster-investigational-new-drug-timelines-with-a-robust-cell-line-development-strategy/ 2023-10-19T22:44:36+00:00 https://old.international-pharma.com/option-1-pressures-on-how-roller-compaction-is-helping-pharmas-formulators-achieve-better-poorly-soluble-api-delivery/ 2023-10-19T22:44:35+00:00 https://old.international-pharma.com/crystallisation-development-a-quality-by-design-approach-using-modelling/ 2023-10-19T22:44:35+00:00 https://old.international-pharma.com/applying-advanced-powder-testing-to-tackle-the-toughest-formulation-challenges/ 2023-10-19T22:44:34+00:00 https://old.international-pharma.com/the-new-age-in-strategic-outsourcing-lies-in-the-mature-portfolio/ 2023-10-19T22:44:33+00:00 https://old.international-pharma.com/pathway-for-marketing-authorisation-approval-of-medical-device-in-us/ 2023-10-19T22:44:33+00:00 https://old.international-pharma.com/pharmas-time-to-jointly-redefine-healthcare-is-now/ 2023-10-19T22:44:32+00:00 https://old.international-pharma.com/latest-developments-in-ip-strategies-for-pharmaceuticals/ 2023-10-19T22:44:31+00:00 https://old.international-pharma.com/pda-europe-annex-1-workshop/ 2023-10-19T22:44:27+00:00 https://old.international-pharma.com/annex-1-implementation-of-the-final-draft/ 2023-10-19T22:44:27+00:00 https://old.international-pharma.com/recommendation-for-novartis-chronic-myeloid-leukaemia-stamp-inhibitor/ 2023-10-19T22:44:26+00:00 https://old.international-pharma.com/sanofis-xenpozyme-approved-by-european-commission/ 2023-10-19T22:44:25+00:00 https://old.international-pharma.com/advanz-finalises-acquisition-of-intercept-operations-across-europe-and-canada/ 2023-10-19T22:44:24+00:00 https://old.international-pharma.com/innovative-trials-acquires-first-us-office/ 2023-10-19T22:44:24+00:00 https://old.international-pharma.com/blooms-smart-crp-test-gets-green-light/ 2023-10-19T22:44:23+00:00 https://old.international-pharma.com/fda-advisory-committee-to-review-amylyx-als-drug-again/ 2023-10-19T22:44:22+00:00 https://old.international-pharma.com/alzecures-alzheimers-candidate-shows-promise/ 2023-10-19T22:44:22+00:00 https://old.international-pharma.com/urovant-licenses-overactive-bladder-drug-to-pierre-fabre/ 2023-10-19T22:44:21+00:00 https://old.international-pharma.com/touchlight-signs-patent-agreement-with-pfizer/ 2023-10-19T22:44:17+00:00 https://old.international-pharma.com/nice-recommends-janssens-treatment-for-active-psoriatic-arthritis/ 2023-10-19T22:44:16+00:00 https://old.international-pharma.com/nice-recommends-use-of-leo-pharmas-adtralza/ 2023-10-19T22:44:15+00:00 https://old.international-pharma.com/diabetes-patients-to-benefit-from-10m-heart-disease-data-investment/ 2023-10-19T22:44:15+00:00 https://old.international-pharma.com/astrazeneca-and-daiichi-sankyos-enhertu-receives-eu-approval/ 2023-10-19T22:44:14+00:00 https://old.international-pharma.com/ema-validates-application-for-byondis-trastuzumab-duocarmazine/ 2023-10-19T22:44:13+00:00 https://old.international-pharma.com/monkeypox-cases-prompt-governments-to-order-vaccine-supply/ 2023-10-19T22:44:13+00:00 https://old.international-pharma.com/ec-authorisation-granted-to-kidney-disease-treatment-kinpeygo/ 2023-10-19T22:44:12+00:00 https://old.international-pharma.com/boots-introduces-new-at-home-health-checks/ 2023-10-19T22:44:11+00:00 https://old.international-pharma.com/roches-combination-breast-cancer-treatment-delivers-positive-results/ 2023-10-19T22:44:11+00:00 https://old.international-pharma.com/new-hampshire-pharmaceutical-development-and-clinical-manufacturing-facility-nears-completion/ 2023-10-19T22:44:06+00:00 https://old.international-pharma.com/wp-content/uploads/2022/07/SGS.png https://old.international-pharma.com/tower-cold-chain-secures-further-investment-to-supercharge-its-success/ 2023-10-19T22:44:06+00:00 https://old.international-pharma.com/wp-content/uploads/2022/07/Tower-Cold-Chain-Product-Range.jpg https://old.international-pharma.com/wp-content/uploads/2022/07/Robust-Reliable-Reusable-temperature-controlled-protection-for-pharmaceuticals.jpg https://old.international-pharma.com/wp-content/uploads/2022/07/Niall-Balfour-CEO-Tower-Cold-Chain.jpg https://old.international-pharma.com/aurinia-receives-positive-chmp-opinion-for-lupkynis/ 2023-10-19T22:44:05+00:00 https://old.international-pharma.com/connect-in-pharma-launches-art-exhibition-and-charity-partnership-to-raise-funds-for-rare-disease-research/ 2023-10-19T22:44:05+00:00 https://old.international-pharma.com/mhra-grants-marketing-authorisation-for-global-blood-therapeuticss-oxbryta/ 2023-10-19T22:44:04+00:00 https://old.international-pharma.com/iconovo-receives-883800-grant-from-the-bill-melinda-gates-foundation/ 2023-10-19T22:44:03+00:00 https://old.international-pharma.com/novo-nordisk-once-weekly-insulin-hits-phase-3-goals/ 2023-10-19T22:44:02+00:00 https://old.international-pharma.com/pci-pharma-services-announces-multi-million-dollar-expansion-to-uk-manufacturing-facility-to-meet-growing-demand-for-global-high-potent-manufacturing-services-supporting-oncology-treatments/ 2023-10-19T22:44:02+00:00 https://old.international-pharma.com/wp-content/uploads/2022/07/PCI-.jpg https://old.international-pharma.com/ipsen-inks-deal-to-take-two-marengo-oncology-drugs-to-the-clinic/ 2023-10-19T22:44:01+00:00 https://old.international-pharma.com/bms-opdivo-yervoy-combo-fails-in-kidney-cancer-trial/ 2023-10-19T22:44:00+00:00 https://old.international-pharma.com/scientists-to-rewrite-dna-in-search-for-heart-disease-cure/ 2023-10-19T22:43:56+00:00 https://old.international-pharma.com/cyclerion-reveals-data-for-schizophrenia-therapy/ 2023-10-19T22:43:55+00:00 https://old.international-pharma.com/tallac-announces-first-patient-treated-with-tac-001/ 2023-10-19T22:43:55+00:00 https://old.international-pharma.com/neil-jones-is-appointed-as-the-new-chief-commercial-officer-cco-of-aenova-group/ 2023-10-19T22:43:54+00:00 https://old.international-pharma.com/wp-content/uploads/2022/08/Aenova_Neil-Jones.png https://old.international-pharma.com/syneurx-reveals-results-of-covid-19-candidate-trial/ 2023-10-19T22:43:53+00:00 https://old.international-pharma.com/eqrx-announces-further-results-from-phase-3-trial-of-sugemalimab/ 2023-10-19T22:43:53+00:00 https://old.international-pharma.com/astrazeneca-daiichi-sankyo-grab-first-fda-approval-for-targeted-her2-low-breast-cancer-drug/ 2023-10-19T22:43:52+00:00 https://old.international-pharma.com/merck-jumps-back-into-alzheimers-waters-with-cerevance-pact/ 2023-10-19T22:43:51+00:00 https://old.international-pharma.com/macrogenics-to-cut-workforce-close-satellite-sites/ 2023-10-19T22:43:51+00:00 https://old.international-pharma.com/lynparza-in-combination-with-abiraterone-granted-priority-review-in-us/ 2023-10-19T22:43:50+00:00 https://old.international-pharma.com/evonetix-commences-access-programme-for-synthesised-dna/ 2023-10-19T22:43:46+00:00 https://old.international-pharma.com/santen-launches-ducressa-for-post-cataract-surgery/ 2023-10-19T22:43:45+00:00 https://old.international-pharma.com/nice-recommendation-expands-patient-eligibility-for-abbvies-ozurdex/ 2023-10-19T22:43:44+00:00 https://old.international-pharma.com/mhra-authorises-modernas-omicron-containing-bivalent-booster/ 2023-10-19T22:43:44+00:00 https://old.international-pharma.com/merck-signs-next-gen-rna-collab-with-orna-therapeutics/ 2023-10-19T22:43:43+00:00 https://old.international-pharma.com/the-national-institute-for-health-and-care-excellence-issues-positive-appraisal-consultation-document-acd-for-eisais-kisplyx-lenvatinib-in-combination-with-msds-keytruda/ 2023-10-19T22:43:42+00:00 https://old.international-pharma.com/fda-approves-axsome-first-rapid-acting-antidepressant/ 2023-10-19T22:43:41+00:00 https://old.international-pharma.com/gilead-grabs-its-first-approval-for-twice-yearly-hiv-therapy/ 2023-10-19T22:43:41+00:00 https://old.international-pharma.com/alcon-to-buy-aerie-pharmaceuticals-for-770m/ 2023-10-19T22:43:40+00:00 https://old.international-pharma.com/fda-fast-tracks-merck-anticoagulant/ 2023-10-19T22:43:36+00:00 https://old.international-pharma.com/ema-accepts-application-for-leukaemia-drug-from-otsuka-and-astex/ 2023-10-19T22:43:35+00:00 https://old.international-pharma.com/new-study-use-musical-tests-for-early-detection-of-cognitive-decline/ 2023-10-19T22:43:35+00:00 https://old.international-pharma.com/shortlist-announced-for-inaugural-sustainable-medicines-packaging-awards/ 2023-10-19T22:43:34+00:00 https://old.international-pharma.com/wp-content/uploads/2022/08/Connect-in-Pharma_Sustainable-Meds-Packaging-Awards-3-logos-Final30.jpg https://old.international-pharma.com/acg-to-launch-german-process-laboratory-in-2023/ 2023-10-19T22:43:33+00:00 https://old.international-pharma.com/mits-ai-model-can-detect-parkinsons-by-tracking-breathing-patterns/ 2023-10-19T22:43:32+00:00 https://old.international-pharma.com/neurocrine-biosciences-to-buy-diurnal/ 2023-10-19T22:43:32+00:00 https://old.international-pharma.com/novartis-scemblix-approved-by-the-ec-for-adults-with-chronic-myeloid-leukaemia/ 2023-10-19T22:43:31+00:00 https://old.international-pharma.com/a-more-connected-future-for-pharma/ 2023-10-19T22:43:30+00:00 https://old.international-pharma.com/wp-content/uploads/2022/09/Wilfried_Phipps_BW0144.jpg https://old.international-pharma.com/european-commission-approves-pharma-trios-ranivisio/ 2023-10-19T22:43:30+00:00 https://old.international-pharma.com/trilogy-writing-consulting-gains-pif-tick-accreditation-to-be-recognised-as-a-trusted-information-creator/ 2023-10-19T22:43:25+00:00 https://old.international-pharma.com/manus-bio-receives-additional-funding-to-combat-malaria/ 2023-10-19T22:43:24+00:00 https://old.international-pharma.com/green-light-for-cancer-drugs-developed-by-ai-specialist-owkin/ 2023-10-19T22:43:23+00:00 https://old.international-pharma.com/avacta-announces-clinical-study-of-ava6000/ 2023-10-19T22:43:23+00:00 https://old.international-pharma.com/first-patient-enrolled-in-modus-sevuparin-trial/ 2023-10-19T22:43:22+00:00 https://old.international-pharma.com/valneva-and-vbi-announce-partnership-for-hepatitis-b-vaccine/ 2023-10-19T22:43:21+00:00 https://old.international-pharma.com/bioinnovation-institute-reveals-new-cohort-entering-venture-lab-programme/ 2023-10-19T22:43:21+00:00 https://old.international-pharma.com/positive-phase-3-data-for-sanofis-dupixent/ 2023-10-19T22:43:20+00:00 https://old.international-pharma.com/stada-launches-prostate-cancer-treatment-across-21-european-countries/ 2023-10-19T22:43:19+00:00 https://old.international-pharma.com/brand-new-state-of-the-art-nemera-offices-inaugurated-in-lyon/ 2023-10-19T22:43:19+00:00 https://old.international-pharma.com/wp-content/uploads/2022/09/Nemera_Building-hall.jpg https://old.international-pharma.com/wp-content/uploads/2022/09/Nemera-team.jpg https://old.international-pharma.com/wp-content/uploads/2022/09/Nemera_Welcome-desk-scaled.jpg https://old.international-pharma.com/vistagen-to-continue-social-anxiety-nasal-spray-trials/ 2023-10-19T22:43:14+00:00 https://old.international-pharma.com/imara-offloads-sickle-cell-drug-to-cardurion/ 2023-10-19T22:43:14+00:00 https://old.international-pharma.com/robotic-automation-solutions-for-pharmas-evolution/ 2023-10-19T22:43:13+00:00 https://old.international-pharma.com/wp-content/uploads/2022/09/Staubli_AST_stoppering-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2022/09/Staubli_Sebastien_Lagarde_Staubli.jpg https://old.international-pharma.com/wp-content/uploads/2022/09/Staubli_TX2_60_stericlean.png https://old.international-pharma.com/alzecures-acd856-research-shows-positive-impact-on-brain/ 2023-10-19T22:43:12+00:00 https://old.international-pharma.com/canserv-rolls-out-cancer-research-services-across-europe/ 2023-10-19T22:43:12+00:00 https://old.international-pharma.com/chmp-recommends-sanofi-and-astrazenecas-beyfortus-to-treat-respiratory-syncytial-virus/ 2023-10-19T22:43:11+00:00 https://old.international-pharma.com/leo-pharma-receives-positive-chmp-opinion-of-adtralza/ 2023-10-19T22:43:10+00:00 https://old.international-pharma.com/genscript-and-avectas-link-up-to-improve-non-viral-cell-therapy-processes/ 2023-10-19T22:43:10+00:00 https://old.international-pharma.com/acg-the-global-pharmaceutical-solutions-company-on-a-mission-to-help-manufacturers-keep-their-supply-chains-moving/ 2023-10-19T22:43:09+00:00 https://old.international-pharma.com/wp-content/uploads/2022/09/ACG-Supply-chain-image-retouch-002.jpg https://old.international-pharma.com/aptar-expands-pharmaceutical-services-announces-exclusive-collaboration-between-aptar-pharma-and-fluidda/ 2023-10-19T22:43:08+00:00 https://old.international-pharma.com/wp-content/uploads/2022/09/Aptar-Fluidda-1480x1080-1.jpg https://old.international-pharma.com/debut-event-showcases-newest-trends-in-drug-manufacturing-and-delivery/ 2023-10-19T22:43:04+00:00 https://old.international-pharma.com/wp-content/uploads/2022/09/Connect-in-Pharma.jpg https://old.international-pharma.com/modus-completes-recruitment-for-sevuparin-study/ 2023-10-19T22:43:03+00:00 https://old.international-pharma.com/navigo-and-mannin-agree-to-develop-a-novel-drug-for-treating-covid-19/ 2023-10-19T22:43:03+00:00 https://old.international-pharma.com/award-winning-paper-securityseal/ 2023-10-19T22:43:02+00:00 https://old.international-pharma.com/wp-content/uploads/2022/09/Securikett-1.png https://old.international-pharma.com/wp-content/uploads/2022/09/Securikett-2.png https://old.international-pharma.com/wp-content/uploads/2022/09/Securikett-3.png https://old.international-pharma.com/wp-content/uploads/2022/09/Securikett-4.jpg https://old.international-pharma.com/wp-content/uploads/2022/09/Securikett-5.png https://old.international-pharma.com/research-reveals-chaotic-schedule-for-myeloma-patients/ 2023-10-19T22:43:02+00:00 https://old.international-pharma.com/cphi-pharma-award-finalists-announced-at-connect-to-frankfurt/ 2023-10-19T22:43:01+00:00 https://old.international-pharma.com/sanofi-mirecule-join-forces/ 2023-10-19T22:43:00+00:00 https://old.international-pharma.com/astrazeneca-rare-disease-to-acquire-logicbio/ 2023-10-19T22:43:00+00:00 https://old.international-pharma.com/junk-dna-may-hold-the-key-to-neurological-disorders/ 2023-10-19T22:42:59+00:00 https://old.international-pharma.com/eli-lilly-receives-marketing-authorisation-for-baricitinib/ 2023-10-19T22:42:58+00:00 https://old.international-pharma.com/tive-announces-a-validated-complete-cold-chain-solution-for-the-pharmaceutical-biologicals-industries/ 2023-10-19T22:42:54+00:00 https://old.international-pharma.com/wp-content/uploads/2022/10/Tive_TT-7100-with-Dry-Ice-Probe_GB-Edit_091322-004.png https://old.international-pharma.com/third-party-testing-to-meet-new-guidelines-for-pharma-robots/ 2023-10-19T22:42:53+00:00 https://old.international-pharma.com/wp-content/uploads/2022/10/Staubli_Robot_riboflavin_cleaning-1-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2022/10/Staubli_engineer_cleanroom_test-scaled.jpg https://old.international-pharma.com/paving-the-way-to-a-more-sustainable-future/ 2023-10-19T22:42:52+00:00 https://old.international-pharma.com/supply-chain-disruptions-bring-short-notice-changes-to-ingredients-but-can-your-labelling-and-artwork-management-system-cope/ 2023-10-19T22:42:52+00:00 https://old.international-pharma.com/patient-centric-clinical-trials-turning-opportunities-into-standard-procedures/ 2023-10-19T22:42:51+00:00 https://old.international-pharma.com/smis-and-soft-mist-nasal-sprays-a-key-defence-in-the-fight-against-the-next-pandemic/ 2023-10-19T22:42:50+00:00 https://old.international-pharma.com/choosing-and-developing-user-friendly-osmotic-laxatives-for-a-more-patient-centric-portfolio/ 2023-10-19T22:42:50+00:00 https://old.international-pharma.com/pci-pharma-services-robotic-aseptic-processing/ 2023-10-19T22:42:49+00:00 https://old.international-pharma.com/how-product-inspection-drives-quality-in-liquid-pharmaceuticals/ 2023-10-19T22:42:49+00:00 https://old.international-pharma.com/modular-cleanroom-technologies-have-always-been-the-answer-to-biopharmas-global-growth-and-flexibility-needs/ 2023-10-19T22:42:48+00:00 https://old.international-pharma.com/whats-in-store-for-aseptic-processing-technologies-in-2022-and-beyond/ 2023-10-19T22:42:44+00:00 https://old.international-pharma.com/flexible-manufacturing-environments-are-vital-for-todays-potent-oral-dose-forms/ 2023-10-19T22:42:43+00:00 https://old.international-pharma.com/solid-form-services-bridging-the-gap-between-drug-substance-and-drug-product/ 2023-10-19T22:42:43+00:00 https://old.international-pharma.com/testing-excipients-for-3d-printed-pharamceuticals/ 2023-10-19T22:42:42+00:00 https://old.international-pharma.com/advances-in-manufacturing-and-processing-impacting-formulation-development/ 2023-10-19T22:42:41+00:00 https://old.international-pharma.com/why-the-right-approach-to-data-management-will-enable-the-potential-of-small-molecule-rna-sodifiers-as-drug-targets-to-be-fulfilled/ 2023-10-19T22:42:40+00:00 https://old.international-pharma.com/handling-with-care-aseptic-dip-coating-for-osteoporosis-treatment/ 2023-10-19T22:42:40+00:00 https://old.international-pharma.com/new-technology-and-automation-in-labs-data-risks-and-privacy-compliance-issues/ 2023-10-19T22:42:39+00:00 https://old.international-pharma.com/the-use-of-predictive-analytics-to-improve-quality-in-clinical-trials-quality-assurance/ 2023-10-19T22:42:38+00:00 https://old.international-pharma.com/the-transformational-potential-of-prioritising-data-today/ 2023-10-19T22:42:38+00:00 https://old.international-pharma.com/the-pharma-drug-discovery-industry-should-look-towards-manufacturing-as-the-blueprint-for-automation/ 2023-10-19T22:42:34+00:00 https://old.international-pharma.com/virtual-screening-in-modern-computational-chemistry/ 2023-10-19T22:42:33+00:00 https://old.international-pharma.com/under-pressure-finding-a-more-sustainable-future-for-pmdis/ 2023-10-19T22:42:32+00:00 https://old.international-pharma.com/use-of-high-field-nmr-in-covid-19-drug-development/ 2023-10-19T22:42:32+00:00 https://old.international-pharma.com/a-business-growth-tool-patent-claiming-strategies/ 2023-10-19T22:42:31+00:00 https://old.international-pharma.com/a-prognosis-of-sustainability-in-the-pharmaceutical-industry/ 2023-10-19T22:42:30+00:00 https://old.international-pharma.com/why-we-recognise-hiv-vaccine-awareness-day/ 2023-10-19T22:42:30+00:00 https://old.international-pharma.com/tive-2/ 2023-10-19T22:42:29+00:00 https://old.international-pharma.com/wp-content/uploads/2022/10/Tive_TT-7100-with-Dry-Ice-Probe_GB-Edit_091322-004.png https://old.international-pharma.com/brainomix-in-collaboration-with-uk-government-funded-ncimi/ 2023-10-19T22:42:28+00:00 https://old.international-pharma.com/chargepoint-technology-collaborates-with-steris-to-deliver-sterile-solution-success-for-evonik/ 2023-10-19T22:42:28+00:00 https://old.international-pharma.com/alzecure-demonstrates-disease-modifying-effects-of-neurorestore-acd856/ 2023-10-19T22:42:24+00:00 https://old.international-pharma.com/positive-results-from-trial-of-arecors-insulin-candidate-at247/ 2023-10-19T22:42:23+00:00 https://old.international-pharma.com/bankrupt-zosano-sells-intradermal-delivery-tech-to-emergex-vaccines/ 2023-10-19T22:42:22+00:00 https://old.international-pharma.com/surge-raises-26m-to-take-anti-cancer-extended-release-hydrogel-into-the-clinic/ 2023-10-19T22:42:22+00:00 https://old.international-pharma.com/love-pharma-moves-to-buy-transdermal-opioid-use-disorder-player/ 2023-10-19T22:42:21+00:00 https://old.international-pharma.com/fda-approves-single-vial-version-of-gsks-menveo-vaccine-ending-need-for-reconstitution/ 2023-10-19T22:42:20+00:00 https://old.international-pharma.com/roche-recalls-new-eye-therapy-susvimo-on-leakage-fears-aims-for-market-return-within-a-year-or-so/ 2023-10-19T22:42:20+00:00 https://old.international-pharma.com/pci-pharma-services-2/ 2023-10-19T22:42:19+00:00 https://old.international-pharma.com/kite-and-refuge-biotechnologies-to-work-together-to-research-blood-cancer/ 2023-10-19T22:42:18+00:00 https://old.international-pharma.com/secure-product-digitalization-with-gambling-features/ 2023-10-19T22:42:18+00:00 https://old.international-pharma.com/wp-content/uploads/2022/10/Securikett-1.png https://old.international-pharma.com/wp-content/uploads/2022/10/Securikett-2.png https://old.international-pharma.com/wp-content/uploads/2022/10/Securikett-3.png https://old.international-pharma.com/wp-content/uploads/2022/10/Securikett-4.png https://old.international-pharma.com/icr-scientists-study-cancer-response-to-new-class-of-drugs/ 2023-10-19T22:42:13+00:00 https://old.international-pharma.com/icrs-new-study-tracks-disease-progression-in-children-with-rare-type-of-cancer/ 2023-10-19T22:42:13+00:00 https://old.international-pharma.com/longitude-prize-on-dementia-launches-with-1m-grand-prize/ 2023-10-19T22:42:12+00:00 https://old.international-pharma.com/uks-largest-health-research-programme-launched/ 2023-10-19T22:42:11+00:00 https://old.international-pharma.com/merck-to-donate-vaccine-doses-to-iavi-for-sudan-ebola-virus/ 2023-10-19T22:42:10+00:00 https://old.international-pharma.com/alpine-stops-clinical-study-enrollment-following-patient-deaths/ 2023-10-19T22:42:09+00:00 https://old.international-pharma.com/exelixis-announces-results-from-trial-evaluating-xb002/ 2023-10-19T22:42:09+00:00 https://old.international-pharma.com/fda-pushes-decision-date-for-perrigo-otc-oral-contraceptive/ 2023-10-19T22:42:08+00:00 https://old.international-pharma.com/gsks-anaemia-drug-gets-fda-advisory-committee-support-for-patients-on-dialysis/ 2023-10-19T22:42:07+00:00 https://old.international-pharma.com/new-evidence-review-uncovers-significant-link-between-particulate-matter-and-dementia/ 2023-10-19T22:42:06+00:00 https://old.international-pharma.com/cphi-excellence-in-pharma-award-winners-2022/ 2023-10-19T22:42:02+00:00 https://old.international-pharma.com/astrazenecas-farxiga-data-shows-widespread-undiagnosed-chronic-kidney-disease/ 2023-10-19T22:42:01+00:00 https://old.international-pharma.com/leva-clinic-fundraises-3m-for-uks-first-digital-chronic-pain-platform/ 2023-10-19T22:42:01+00:00 https://old.international-pharma.com/rivus-presents-results-from-trial-evaluating-controlled-metabolic-accelerator/ 2023-10-19T22:42:00+00:00